Yardstick Research tear-sheet / healthcare RCM cohort

Methodology · how we score · rubric weights in plain sight · vendors received this sheet seven days before publication and could flag factual errors, never rankings

Smarterdx

Identity

SmarterDx (now a wholly owned business unit of Smarter Technologies post-May 2025 rollup; product line: SmarterPrebill, SmarterDenials, SmarterCharges, SmarterUtilization, SmarterNotes). Founded 2020 in New York City by two physician-data scientists, Michael Gao, MD and Joshua Geleris, MD. HQ: NYC (legacy SmarterDx, 169 Madison Ave) / Dallas (Smarter Technologies parent). ~368 employees per LinkedIn (post-rollup; pre-rollup SmarterDx-only headcount estimated ~100-150). $71M total raised pre-rollup (Seed April 2022 Flare+Floodgate, Series A April 2023 Bessemer, $50M Series B May 2024 led by Transformation Capital), then strategic growth investment from New Mountain Capital April 2025, then folded into Smarter Technologies May 18, 2025 alongside Thoughtful.ai + Access Healthcare ($800M+ combined revenue per Hospitalogy). CEO Michael Gao now serves as President of Smarter Technologies. 85+ health systems and 300+ hospital sites in production.

Total score: 74 / 100

(weighted dimension total = 75.00; pricing-transparency penalty = soft, ~1 point deduction → 74)

• Stage fit:
• Foundation (<40 readiness): conditional - the contingency-pricing model lowers the readiness bar (no upfront capex, no minimum-volume floor), so a Foundation-stage buyer CAN start a SmarterDx engagement without an internal AI program in place. The caveat is integration-engineering capacity: a SmarterDx deployment still requires Epic Bridges / Cerner CCL connectivity work on the customer side, and a Foundation-stage health system without integration-engineering bench will need to source that externally.
• Pilot (40-59): yes - this is the cleanest fit. The contingency model functions effectively as a built-in pilot - "if they don't find you more revenue, you don't pay" - and Novant Health's 8-week, 15-site deployment is the published proof point.
• Scale (60-79): yes - Scale-stage CDI programs with multi-campus inpatient volume are exactly the operating profile where the per-10K-discharge ROI math compounds.
• Optimization (80+): yes, with the post-rollup caveat - large IDNs running the full Smarter Technologies stack (SmarterPrebill + SmarterNotes + Thoughtful workflows + Access Healthcare BPO) is what New Mountain is monetizing. The integrated-platform story is roadmap-stage as of research date; Optimization-stage buyers should ask for integrated-stack customer references before committing to the bundled pitch.
• One-line verdict: The strongest contingency-pricing pick in healthcare-RCM revenue integrity - bring it in when you're a 200+ bed Epic-or-Cerner shop with centralized CDI, want a pre-bill chart-review layer over your existing CDI tool, and prefer a revenue-share commercial structure to a SaaS subscription.

Headline numbers

Dimension scores

Pricing detail

• Model: Contingency revenue share. Health systems pay only on findings that are approved and result in billed claims. No upfront fee, no per-discharge SaaS subscription, no minimum-volume floor.
• Revenue-share percentage: NOT publicly disclosed. Industry-typical revenue-cycle contingency contracts run 15-25%; SmarterDx's actual split is negotiated per health system.
• Implied per-discharge $ to SmarterDx: [ESTIMATED] If the typical revenue-share is 15-25% and the vendor-claimed $2-3.5M per 10K discharges of new revenue is accurate, implied per-discharge revenue to SmarterDx is roughly $30-90. Buyers in active procurement should ask for the negotiated revenue-share percentage and the typical "findings per 1,000 charts" baseline.
• No /pricing page at all (smarterdx.com/pricing returns 404 as of research date). Wayback returned no archived /pricing snapshots - baseline opaque, not a regression.
• Pricing-transparency penalty: SOFT - vendor is unambiguously enterprise-focused (size_fit_min = $250M NPR), and the contingency model bounds buyer downside at zero. The rubric prescribes soft per Section 6.7. The contingency-model buyer-friendliness is noted as a mitigating factor in the editorial but the rubric does not grade-down for it.

Integrations

• EHR (native, vendor-claimed + corroborated): Epic (deployed at Novant, OHSU, UCHealth; explicit Epic Bridges / Clarity / Chronicles expertise in hiring), Cerner (Cerner CCL expertise in hiring)
• EHR (NOT publicly named): Meditech, Allscripts, NextGen - no evidence of native connectors
• Epic certification tier: NOT publicly disclosed (CodaMetrix has Epic Toolbox; SmarterDx does not have an equivalent published designation)
• Hosting cloud: NOT publicly disclosed
• Clearinghouse partners: NONE publicly disclosed (SmarterDx sits upstream of the clearinghouse - produces revenue-integrity findings before claims are submitted)
• Post-rollup integration with Smarter Technologies stack: SmarterNotes (Sept 2025) combines SmarterDx clinical AI with Pieces Technologies documentation AI; Thoughtful.ai workflow automation + Access Healthcare BPO are positioned as integrated stack components but production-ready integration status NOT independently verified
• Marketplace presence: none surfaced

Layer 4 stack-rank fields

layer4_fields:
  size_fit_min_revenue: 250
  size_fit_max_revenue: 50000
  ai_native_score: 75
  integrates_with: [epic, cerner]

Editorial assessment

SmarterDx is the strongest contingency-pricing pick in healthcare-RCM revenue integrity, and the most commercially differentiated entry in the cohort. The platform addresses a different procurement problem than the autonomous-coding category (CodaMetrix, Fathom, Nym) and a different one than the broad workflow-automation category (AKASA, R1 RCM). Where CodaMetrix asks a CFO "convert your manual coder labor to autonomous coding and we'll bill you for the SaaS," SmarterDx asks the same CFO "give us the right to review every chart at prebill, and we'll take a share of the revenue we find that you would have missed." For a buyer who has been burned by SaaS subscriptions that underdelivered, the SmarterDx commercial structure - "you only pay out of money we find you that you wouldn't have captured otherwise" - is meaningfully de-risked.

Customer evidence supports the pitch: McLaren $11.3M annual, UAMS $5.3M annual, Novant Health doubled their projected revenue capture across 15 sites in 8 weeks. KLAS Emerging Solutions report records 100% "highly satisfied," 100% "outcomes immediately," and a 98 customer-satisfaction score. The 85+ health system / 300+ hospital site footprint, pre-rollup ~$100M ARR (Hospitalogy), and 5X-year-on-year revenue growth (Flare Capital) triangulate to an enterprise-credible operation. Day-One 5:1 ROI is the most-cited TTV number across vendor PR + analyst commentary + customer case studies.

The most consequential thing in the research window is the May 2025 rollup into Smarter Technologies. New Mountain Capital combined SmarterDx with Thoughtful.ai (workflow automation), Access Healthcare (offshore RCM BPO), and four months later Pieces Technologies (clinical-note AI) into an $800M+ combined-revenue platform. Michael Gao moved from SmarterDx CEO to Smarter Technologies President. For buyers, this changes procurement in three ways: contract entity is shifting from SmarterDx Inc. to Smarter Technologies LLC, product roadmap is now subject to platform-level prioritization across four product lines, and the post-rollup integrated story (SmarterPrebill + SmarterNotes + Thoughtful workflows + Access Healthcare BPO) is what New Mountain is monetizing. Buyers in active procurement should ask which integrations are production-ready vs. roadmap-stage, and which entity owns the contract going forward.

Where the scoring marks down: data + compliance disclosure. SmarterDx publishes a SOC 2 + KLAS badge in the site footer and nothing more - no public HITRUST attestation, no /trust page, no /security page, no named CISO, no AI-training-data isolation policy, no hosting cloud disclosed. For a vendor processing PHI on 85+ health systems, this is below the public-disclosure bar a healthcare-RCM CISO will expect. The operational reality is almost certainly stronger (the customer roster requires HITRUST-equivalent BAAs in place under NDA) - but Yardstick scores what buyers can see, and the public surface is thin. The newly-relevant question post-rollup is offshore data access: Access Healthcare runs large RCM operations in India under the same Smarter Technologies parent; whether SmarterDx PHI processing stays U.S.-only is NOT publicly disclosed. The second integration gap is the absence of a published Epic Toolbox / Showroom designation - the integration capability is clearly there in deployed-customer evidence but the lack of vendor-side Epic certification slows procurement at Epic-governance-rigid health systems.

Where this vendor is the wrong answer: ambulatory-only practices, surgery centers and outpatient diagnostic clinics with no inpatient discharge volume, critical-access hospitals under 100 beds (contracting overhead disproportionate to recovery opportunity), and FQHCs / community health centers running non-Epic / non-Cerner EHRs. The pricing model (contingency on inpatient-prebill findings) and customer roster (mid-to-large nonprofit health systems and regional AMCs) all point at the same buyer profile: a CFO or VP Revenue Integrity at a 200+ bed Epic-or-Cerner shop with multiple campuses and a centralized CDI program.

When to revisit: (1) If SmarterDx or Smarter Technologies publishes a HITRUST attestation, a public /trust page, or names a CISO - the data-compliance dimension re-rates upward materially. (2) If Epic Toolbox or Epic Showroom designation lands - closes the integration-tier gap relative to CodaMetrix. (3) If the post-rollup Smarter Technologies platform publishes integrated-stack customer references with SmarterPrebill + SmarterNotes + Thoughtful workflows deployed together - converts the roadmap story to production-ready. (4) If an independent third-party accuracy audit of the contingency-model findings is published - converts the per-discharge revenue claims from VENDOR-CLAIMED to corroborated. (5) If KLAS introduces a Best in KLAS title for prebill clinical-AI or revenue-integrity, SmarterDx is the clear front-runner based on the 2023 Emerging Solutions panel data.

Right-of-reply gaps

These are the [UNKNOWN] items the vendor should be invited to fill in during the factcheck pipeline:

• HITRUST CSF status (certified, in-progress, or not pursued - at SmarterDx level and at Smarter Technologies parent level)
• SOC 2 Type (I or II), most recent audit date, and audit firm
• Named CISO and post-rollup security-program ownership structure
• Underlying LLM / model provider (proprietary, or external - OpenAI, Anthropic, Google, etc.) and whether customer PHI is excluded from model retraining
• Whether SmarterDx PHI processing remains U.S.-only post-rollup, given Access Healthcare's offshore-India operations now sit under the same Smarter Technologies parent
• Hosting cloud (AWS, Azure, GCP) and data-residency options
• Epic certification tier - Toolbox / Showroom / Connection Hub designation, or none
• Meditech / Allscripts integration availability
• Typical revenue-share percentage in a contingency contract (or at minimum, the typical range)
• Per-discharge implied $ to SmarterDx in a typical 200-bed Epic-shop deployment
• Post-rollup contract-entity clarity (SmarterDx Inc. vs. Smarter Technologies LLC) and what that means for existing-customer contract continuity
• Roadmap-prioritization governance under Smarter Technologies (how SmarterDx-specific roadmap items get prioritized against Thoughtful.ai / Access Healthcare / Pieces roadmap)
• Pre-rollup ARR confirmation (Hospitalogy cites $100M; getlatka cites $71M which appears to mirror funding total)
• Pen-test cadence and report availability under NDA
• Customer-data isolation in model training and feedback-loop retraining cadence
• Confirmation of integrated-stack customer references using SmarterPrebill + SmarterNotes + Thoughtful workflows together in production